BOSTON MEDICAL CENTER BOSTON – Current HIV-1 therapies have been proven to be highly effective in slowing the progression of the virus in the body with only minimal side effects. The daily antiretroviral therapy (ART) uses a combination of HIV-1 medicines. A proportion of patients diagnosed with HIV-1, however, cannot take the ART for many...
Tag: <span>HIV</span>
Post
Antiretroviral HIV medication attenuates liver fibrosis
by Asociacion RUVID Scientists from Valencia University (UV) have discovered that Rilpivirine, an antiretroviral drug used for treating HIV, has beneficial effects on chronic liver diseases. The finding opens a path to identify new therapies for liver diseases. Their work has been published in the journal Gut. Liver fibrosis is a significant health issue worldwide...
Post
What chronic illnesses are people with HIV more likely to experience?
By Ana Sandoiu Fact checked by Paula Field New research looks into the chronic illnesses that people living with HIV are at most risk of developing. In the United States, over 1 million people are currently living with an HIV infection. Worldwide, 1.8 million people have HIV. Overall, the incidence of HIV infections has declined...
Post
Serious falls are a health risk for adults under 65
YALE UNIVERSITY New Haven, Conn. — Adults who take several prescription medications are more likely to experience serious falls, say Yale researchers and their co-authors in a new study. This heightened risk can affect middle-aged individuals — a population not typically viewed as vulnerable to debilitating or fatal falls, the researchers said. To identify factors...
Post
Immune cells reprogrammed to kill HIV-infected T cells
There exists a group of HIV-positive people who have the rare ability to naturally control the HIV infection. Now, after years of research, a team of scientists from the Institut Pasteur in Paris, has successfully reprogrammed cells that lack this ability, giving them the same incredible, antiviral potency. Less than one percent of people living...
Post
Health panel: Millions of US kids should get hepatitis shot
by Mike Stobbe A scientific panel is recommending that more than 2 million U.S. kids get vaccinated against hepatitis A. Thirteen years ago, the Advisory Committee on Immunization Practices recommended hepatitis A shots for all U.S. children at age 1. On Thursday, the panel said the shots should be given to older children who weren’t vaccinated earlier, including 14- to 18-year-olds who turned...
Post
New 3D-printed technology lowers cost of common medical test
UNIVERSITY OF CONNECTICUT A desire for a simpler, cheaper way to do common laboratory tests for medical diagnoses and to avoid “washing the dishes” led University of Connecticut researchers to develop a new technology that reduces cost and time. Their pipette-based technology could also help make certain medical testing available in rural or remote areas where traditional methods might...
Post
SCIENTISTS GENE-EDITED HIV TO CURE “BUBBLE BOY” DISEASE
Normal Lives Researchers from St. Jude Children’s Research Hospital have reportedly used HIV to cure infants born with “bubble boy” disease — a remarkable example of hijacking a deadly virus for a new treatment. “The children are cured,” researcher Ewelina Mamcarz toldNBC News. “They came to us as little infants, some of them as young as 2 months, with severe infections. Now they are home, living...
Post
New Type Of Antibody Can Hold HIV Virus At Bay For 4 Months
A single injection may have prevented the progression of the human immunodeficiency virus, or HIV, to up to four months, a new study suggests. Researchers in Taiwan reported that the antibodycalled UB-421 was safe and it effectively prevented the virus from destroying the immune system. They reported that a single injection of the antibody is as effective as a daily pill regimen. They published the results of...
Post
First two-drug regimen approved for HIV-1 treatment
(HealthDay)—The U.S. Food and Drug Administration has announced the approval of Dovato (dolutegravir and lamivudine), the first approved two-drug, fixed-dose, complete regimen for adults with HIV-1 who have not been previously treated with antiretroviral medication. Dovato is indicated for patients with no known or suspected substitutions associated with resistance to the drug’s individual components. As opposed to the standard-of-care three-drug regimen, Dovato provides patients with the option of...